Novel insights into brain lipid metabolism in Alzheimer's disease: Oligodendrocytes and white matter abnormalities
Open Access
- 26 June 2023
- journal article
- review article
- Published by Wiley in FEBS Open Bio
- Vol. 14 (2) , 194-216
Abstract
Alzheimer's disease (AD) is the most common cause of dementia. A genome‐wide association study has shown that several AD risk genes are involved in lipid metabolism. Additionally, epidemiological studies have indicated that the levels of several lipid species are altered in the AD brain. Therefore, lipid metabolism is likely changed in the AD brain, and these alterations might be associated with an exacerbation of AD pathology. Oligodendrocytes are glial cells that produce the myelin sheath, which is a lipid‐rich insulator. Dysfunctions of the myelin sheath have been linked to white matter abnormalities observed in the AD brain. Here, we review the lipid composition and metabolism in the brain and myelin and the association between lipidic alterations and AD pathology. We also present the abnormalities in oligodendrocyte lineage cells and white matter observed in AD. Additionally, we discuss metabolic disorders, including obesity, as AD risk factors and the effects of obesity and dietary intake of lipids on the brain.Keywords
Funding Information
- Hori Sciences and Arts Foundation
- Japan Agency for Medical Research and Development (JP23wm0425014)
- Japan Society for the Promotion of Science (JP21K20569, JP23K13902)
- Moonshot Research and Development Program (JPMJMS2024)
- Takeda Science Foundation
This publication has 233 references indexed in Scilit:
- Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s diseaseLipids in Health and Disease, 2013
- Body mass index correlates negatively with white matter integrity in the fornix and corpus callosum: A diffusion tensor imaging studyHuman Brain Mapping, 2011
- Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's diseaseJournal of Chemical Neuroanatomy, 2011
- Peroxisomal alterations in Alzheimer’s diseaseActa Neuropathologica, 2011
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer DiseaseJAMA, 2010
- Reduced Lean Mass in Early Alzheimer Disease and Its Association With Brain AtrophyArchives of Neurology, 2010
- Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT‐deficient miceGlia, 2009
- Midlife and Late-Life Obesity and the Risk of DementiaArchives of Neurology, 2009
- Triple‐transgenic Alzheimer's disease mice exhibit region‐specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathologyGlia, 2008
- Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ productionNeurobiology of Disease, 2008